bupivacaine has been researched along with Neuralgia in 65 studies
Bupivacaine: A widely used local anesthetic agent.
1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide : A piperidinecarboxamide obtained by formal condensation of the carboxy group of N-butylpipecolic acid with the amino group of 2,6-dimethylaniline.
bupivacaine : A racemate composed of equimolar amounts of dextrobupivacaine and levobupivacaine. Used (in the form of its hydrochloride hydrate) as a local anaesthetic.
Neuralgia: Intense or aching pain that occurs along the course or distribution of a peripheral or cranial nerve.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Four patients with postherpetic neuralgia had their pain alleviated by epidural administration of ketamine." | 7.71 | [Usefulness of epidural administration of ketamine for relief of postherpetic neuralgia]. ( Ikeda, M; Machida, K; Mikawa, Y; Mizuno, J; Sugimoto, S, 2001) |
| " In the present case report, two patients with reflex sympathetic dystrophy were treated with ketamine, a NMDA antagonist, morphine and bupivacaine." | 7.70 | Long-term epidural ketamine, morphine and bupivacaine attenuate reflex sympathetic dystrophy neuralgia. ( Chen, FC; Ho, ST; Lin, SY; Lin, TC; Wong, CS, 1998) |
| "5% bupivacaine to a patient with post-herpetic neuralgia in the thoracic region." | 7.67 | Horner's syndrome after intrapleural anesthesia with bupivacaine for post-herpetic neuralgia. ( Holmblad, BR; Sihota, MK, 1988) |
| " The result strongly suggests a synergy from this combination that warrants a formal study of the dose-response relationship involved in this treatment and the mechanism by which this effect is achieved." | 5.29 | Epidural coadministration of ketamine, morphine and bupivacaine attenuates post-herpetic neuralgia--a case report. ( Cherng, CH; Ho, ST; Liaw, WJ; Shen, TT; Wong, CS, 1996) |
| " In the second part, eight patients with herpetic neuralgia received epidural analgesia at the fourth to eighth thoracic interspace, using bupivacaine 0." | 5.06 | Cerebrospinal norepinephrine concentrations and the duration of epidural analgesia. ( Fujita, N; Fujita, T; Goto, F, 1990) |
| "In our previous study, we concluded that an epidural blockade combined with intravenous acyclovir is very effective in treating the acute pain in herpes zoster and postherpetic neuralgia." | 3.71 | The effects of famciclovir and epidural block in the treatment of herpes zoster. ( Ahn, HJ; Ahn, SK; Choi, EH; Hwang, SM; Lee, WS; Lee, YB; Lim, HK, 2001) |
| "Four patients with postherpetic neuralgia had their pain alleviated by epidural administration of ketamine." | 3.71 | [Usefulness of epidural administration of ketamine for relief of postherpetic neuralgia]. ( Ikeda, M; Machida, K; Mikawa, Y; Mizuno, J; Sugimoto, S, 2001) |
| " In the present case report, two patients with reflex sympathetic dystrophy were treated with ketamine, a NMDA antagonist, morphine and bupivacaine." | 3.70 | Long-term epidural ketamine, morphine and bupivacaine attenuate reflex sympathetic dystrophy neuralgia. ( Chen, FC; Ho, ST; Lin, SY; Lin, TC; Wong, CS, 1998) |
| "5% bupivacaine to a patient with post-herpetic neuralgia in the thoracic region." | 3.67 | Horner's syndrome after intrapleural anesthesia with bupivacaine for post-herpetic neuralgia. ( Holmblad, BR; Sihota, MK, 1988) |
| "We treated 12 cases of cutaneous herpes zoster (HZ) with epidural bupivacaine and methylprednisolone acetate." | 3.66 | Epidural injection of local anesthetic and steroids for relief of pain secondary to herpes zoster. ( Hanlon, PR; Perkins, HM, 1978) |
| "Peripheral neuropathic pain (PNP) associated with trauma is often refractory to treatment." | 2.82 | Study protocol for a pilot, randomised, double-blinded, placebo controlled trial of perineural local anaesthetics and steroids for chronic post-traumatic neuropathic pain in the ankle and foot: the PREPLANS study. ( Alvi, S; Bhatia, A; Bril, V; Brull, RT; Davis, AM; Gandhi, R; Lau, J; Mahomed, N; Perruccio, A; Wijeysundera, D, 2016) |
| "The frequency of neuropathic pain was assessed using the Douleur Neuropathique 4-question survey (DN4) in the first and second postoperative months." | 2.78 | Effect of the addition of clonidine to locally administered bupivacaine on acute and chronic postmastectomy pain. ( Abdel-Ghaffar, HS; Mohamed, SA, 2013) |
| "Chronic neuropathic pain following traumatic brachial plexus injury could be successfully managed by chemical neurolysis and oral gabapentin." | 1.51 | Management of neuropathic pain following traumatic brachial plexus injury with neurolysis and oral gabapentin: A case report. ( Aaron, OI; Adetoye, AO; Orimolade, EA; P Adetifa, KA, 2019) |
| "Lacrimal neuralgia has been recently described as a pain in the territory supplied by the lacrimal nerve, at the lateral upper eyelid and/or the adjacent area of the temple." | 1.46 | Lacrimal Nerve Blocks for Three New Cases of Lacrimal Neuralgia. ( Cuadrado, ML; García-Moreno, H; Gutiérrez-Viedma, Á; Orviz, A; Silva-Hernández, L, 2017) |
| "Persistent pain after breast cancer surgery (PPBCS) affects 25 - 60% of breast cancer survivors and damage to the intercostobrachial nerve (ICBN) has been implicated as the cause of this predominantly neuropathic pain." | 1.43 | Ultrasound Guided Intercostobrachial Nerve Blockade in Patients with Persistent Pain after Breast Cancer Surgery: A Pilot Study. ( Andersen, KG; Anderson, KG; Duriaud, HM; Kehlet, H; Wijayasinghe, N, 2016) |
| "Patients with neuropathic pain commonly present with spontaneous pain, in addition to allodynia and hyperalgesia." | 1.42 | Conditioned place preference and spontaneous dorsal horn neuron activity in chronic constriction injury model in rats. ( Brennan, TJ; Dalm, BD; Howard, MA; Kang, S; Reddy, CG, 2015) |
| "Antiepileptics used for treating neuropathic pain have various actions including voltage-gated Na(+) and Ca(2+) channels, glutamate-receptor inhibition, and GABA(A)-receptor activation, while local anesthetics are also used to alleviate the pain." | 1.40 | Effects of various antiepileptics used to alleviate neuropathic pain on compound action potential in frog sciatic nerves: comparison with those of local anesthetics. ( Fujita, T; Hirakawa, N; Kumamoto, E; Ohtsubo, S; Sakaguchi, Y; Uemura, Y, 2014) |
| "Levobupivacaine was more potent than lidocaine in all tests employed on diabetic rats." | 1.39 | Comparison of actions of systemically and locally administrated local anaesthetics in diabetic rats with painful neuropathy. ( Gunay, I; Gunes, Y; Mert, T, 2013) |
| "The pathophysiology of many types of chronic headaches is not well understood." | 1.33 | Cervicogenic headache in patients with presumed migraine: missed diagnosis or misdiagnosis? ( Cook, AJ; Hamill-Ruth, RJ; Rowlingson, JC; Yi, X, 2005) |
| "Intercostal neuralgia is one of many possible neurological disorders associated with pregnancy." | 1.29 | Long-term epidural analgesia for pregnancy-induced intercostal neuralgia. ( Dews, TE; Samlaska, S, 1995) |
| " The result strongly suggests a synergy from this combination that warrants a formal study of the dose-response relationship involved in this treatment and the mechanism by which this effect is achieved." | 1.29 | Epidural coadministration of ketamine, morphine and bupivacaine attenuates post-herpetic neuralgia--a case report. ( Cherng, CH; Ho, ST; Liaw, WJ; Shen, TT; Wong, CS, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (15.38) | 18.7374 |
| 1990's | 14 (21.54) | 18.2507 |
| 2000's | 17 (26.15) | 29.6817 |
| 2010's | 22 (33.85) | 24.3611 |
| 2020's | 2 (3.08) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, CC | 1 |
| Chang, CY | 1 |
| Tzeng, CY | 1 |
| Huang, JH | 1 |
| Hung, CJ | 1 |
| Chen, WY | 1 |
| Liao, SL | 1 |
| Kuan, YH | 1 |
| Chen, CJ | 1 |
| Yalamanchili, SP | 1 |
| Hertle, RW | 1 |
| Adetoye, AO | 1 |
| Aaron, OI | 1 |
| Orimolade, EA | 1 |
| P Adetifa, KA | 1 |
| Benkli, B | 1 |
| Ansoanuur, G | 1 |
| Hernandez, N | 1 |
| Ahiskalioglu, A | 1 |
| Alici, HA | 1 |
| Ari, MA | 1 |
| Ju, Y | 1 |
| Tian, D | 1 |
| Tan, Y | 1 |
| Fu, Z | 1 |
| Balaban, O | 1 |
| Aydin, T | 1 |
| Yaman, M | 1 |
| Thompson, EN | 1 |
| Usichenko, T | 1 |
| Cuadrado, ML | 4 |
| Aledo-Serrano, A | 2 |
| Jorquera, M | 1 |
| Porta-Etessam, J | 1 |
| Pareja, JA | 1 |
| Uemura, Y | 1 |
| Fujita, T | 2 |
| Ohtsubo, S | 1 |
| Hirakawa, N | 1 |
| Sakaguchi, Y | 1 |
| Kumamoto, E | 1 |
| Iwanowski, P | 1 |
| Kozubski, W | 1 |
| Losy, J | 1 |
| García-Moreno, H | 3 |
| Gimeno-Hernández, J | 1 |
| Cohen, SP | 1 |
| Peterlin, BL | 1 |
| Fulton, L | 1 |
| Neely, ET | 1 |
| Kurihara, C | 1 |
| Gupta, A | 1 |
| Mali, J | 1 |
| Fu, DC | 1 |
| Jacobs, MB | 1 |
| Plunkett, AR | 1 |
| Verdun, AJ | 1 |
| Stojanovic, MP | 1 |
| Hanling, S | 1 |
| Constantinescu, O | 1 |
| White, RL | 1 |
| McLean, BC | 1 |
| Pasquina, PF | 1 |
| Zhao, Z | 1 |
| Dalm, BD | 1 |
| Reddy, CG | 1 |
| Howard, MA | 1 |
| Kang, S | 1 |
| Brennan, TJ | 1 |
| Hayek, SM | 1 |
| Sweet, JA | 1 |
| Miller, JP | 1 |
| Sayegh, RR | 1 |
| Wijayasinghe, N | 1 |
| Duriaud, HM | 1 |
| Kehlet, H | 1 |
| Andersen, KG | 1 |
| Anderson, KG | 1 |
| Bhatia, A | 1 |
| Bril, V | 1 |
| Brull, RT | 1 |
| Perruccio, A | 1 |
| Wijeysundera, D | 1 |
| Alvi, S | 1 |
| Lau, J | 1 |
| Gandhi, R | 1 |
| Mahomed, N | 1 |
| Davis, AM | 1 |
| Gutiérrez-Viedma, Á | 1 |
| Silva-Hernández, L | 1 |
| Orviz, A | 1 |
| Xie, W | 1 |
| Strong, JA | 1 |
| Zhang, JM | 1 |
| Hahn, L | 1 |
| Mert, T | 1 |
| Gunes, Y | 1 |
| Gunay, I | 1 |
| Guirguis, MN | 1 |
| Abd-Elsayed, AA | 1 |
| Girgis, G | 1 |
| Soliman, LM | 1 |
| Klessinger, S | 1 |
| Mohamed, SA | 1 |
| Abdel-Ghaffar, HS | 1 |
| Hough, DM | 1 |
| Wittenberg, KH | 1 |
| Pawlina, W | 1 |
| Maus, TP | 1 |
| King, BF | 1 |
| Vrtiska, TJ | 1 |
| Farrell, MA | 1 |
| Antolak, SJ | 1 |
| Gruber, H | 1 |
| Bodner, G | 1 |
| Mason, JO | 1 |
| Katz, B | 1 |
| Greene, HH | 1 |
| McAllister, RK | 1 |
| Carpentier, BW | 1 |
| Malkuch, G | 1 |
| Hardy, D | 1 |
| Yi, X | 1 |
| Cook, AJ | 1 |
| Hamill-Ruth, RJ | 1 |
| Rowlingson, JC | 1 |
| Naja, MZ | 1 |
| Al-Tannir, MA | 1 |
| Maaliki, H | 1 |
| El-Rajab, M | 1 |
| Ziade, MF | 1 |
| Zeidan, A | 1 |
| Wen, YR | 1 |
| Suter, MR | 1 |
| Kawasaki, Y | 1 |
| Huang, J | 1 |
| Pertin, M | 1 |
| Kohno, T | 1 |
| Berde, CB | 1 |
| Decosterd, I | 1 |
| Ji, RR | 1 |
| Ju, H | 1 |
| Feng, Y | 1 |
| Yang, BX | 1 |
| Wang, J | 1 |
| Laban, MM | 1 |
| Grant, AJ | 1 |
| Wood, C | 1 |
| Miller, I | 1 |
| Schreuder, M | 1 |
| Khoury, R | 1 |
| Kennedy, SF | 1 |
| Macnamara, TE | 1 |
| Rifat, SF | 1 |
| Lombardo, JA | 1 |
| Cheema, SP | 1 |
| Ilsley, D | 1 |
| Richardson, J | 1 |
| Sabanathan, S | 1 |
| Samlaska, S | 1 |
| Dews, TE | 1 |
| Vanamo, R | 1 |
| Vähämurto, M | 1 |
| Siitonen, O | 1 |
| Wong, CS | 2 |
| Shen, TT | 1 |
| Liaw, WJ | 1 |
| Cherng, CH | 1 |
| Ho, ST | 2 |
| Lin, TC | 1 |
| Chen, FC | 1 |
| Lin, SY | 1 |
| Elias, M | 1 |
| Boezaart, AP | 1 |
| du Toit, JC | 1 |
| van Lill, G | 1 |
| Donald, R | 1 |
| van der Spuy, G | 1 |
| Bolus, M | 1 |
| Hwang, SM | 2 |
| Kang, YC | 1 |
| Lee, YB | 2 |
| Yoon, KB | 1 |
| Ahn, SK | 2 |
| Choi, EH | 2 |
| Bourlon-Figuet, S | 1 |
| Dubousset, AM | 1 |
| Benhamou, D | 1 |
| Mazoit, JX | 1 |
| Ahn, HJ | 1 |
| Lim, HK | 1 |
| Lee, WS | 1 |
| Yokoyama, M | 1 |
| Ohashi, I | 1 |
| Nakatsuka, H | 1 |
| Mizobuchi, S | 1 |
| Toda, Y | 1 |
| Matsumi, M | 1 |
| Morita, K | 1 |
| Hirakawa, M | 1 |
| Mizuno, J | 1 |
| Sugimoto, S | 1 |
| Ikeda, M | 2 |
| Machida, K | 1 |
| Mikawa, Y | 1 |
| Bleeker, CP | 1 |
| Bremer, RC | 1 |
| Dongelmans, DA | 1 |
| van Dongen, RT | 1 |
| Crul, BJ | 1 |
| Perkins, HM | 1 |
| Hanlon, PR | 1 |
| Parris, WC | 1 |
| Currey, TA | 1 |
| Dalsania, J | 1 |
| Klein, DS | 1 |
| Schmidt, RE | 1 |
| Goto, F | 1 |
| Fujita, N | 1 |
| de Vries, N | 1 |
| Smelt, WL | 1 |
| Defalque, RJ | 1 |
| Bromley, JJ | 1 |
| Sihota, MK | 1 |
| Holmblad, BR | 1 |
| Ackerman, WE | 1 |
| Zinke, R | 1 |
| Hannington-Kiff, JG | 1 |
| Swerdlow, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Comparison of Heated vs. Pulsed Radiofrequency Treatment of the Genicular Nerves for Osteoarthritis Knee Pain[NCT04379895] | 60 participants (Anticipated) | Interventional | 2020-06-30 | Not yet recruiting | |||
| A Comparison of Pain Control AND Quality of Life Improvement Between Occipital Nerve Block And Occipital Nerve Radiofrequency Ablation: A Double-Blind Single Center Prospective Study[NCT04124458] | 70 participants (Anticipated) | Interventional | 2023-01-02 | Not yet recruiting | |||
| Pulsed vs Continuous Radiofrequency Neurotomy for Cervical Facet Joint Mediated Pain: a Single-blind Randomized Controlled Clinical Trial[NCT04124445] | 88 participants (Anticipated) | Interventional | 2020-02-10 | Recruiting | |||
| Randomized, Double-blind, Comparative-effectiveness Study Comparing Corticosteroid Injections to Pulsed Radiofrequency for Occipital Neuralgia[NCT01670825] | 81 participants (Actual) | Interventional | 2012-08-31 | Completed | |||
| Greater Occipital Nerve Pulsed Radiofrequency for the Treatment of Combined Migraine and Cervicogenic Headache (New Approach): Randomized Clinical Trial[NCT06121037] | 60 participants (Actual) | Interventional | 2022-01-01 | Completed | |||
| A Pilot Randomized Controlled Trial of Efficacy of Perineural Local Anesthetics and Steroids for Chronic Post-traumatic Neuropathic Pain in the Ankle and the Foot: The PREPLAN Study[NCT02680548] | Early Phase 1 | 8 participants (Actual) | Interventional | 2015-11-30 | Completed | ||
| Pain Control After VATS Anatomical Pulmonary Resections: Randomized Comparison Between Cryoanalgesia, Erector Spinae Plane Block and Epidural Catheter[NCT05993273] | 75 participants (Anticipated) | Interventional | 2023-04-05 | Recruiting | |||
| Cryoanalgesia and Post-thoracotomy Pain in Minimally Invasive Cardiothoracic Surgery[NCT05255146] | 100 participants (Anticipated) | Interventional | 2023-12-31 | Not yet recruiting | |||
| The Effect of Cryoneurolysis for the Treatment of Acute Postoperative Pain Following Total Knee Arthroplasty in High Pain Responders - A Randomized, Participant- and Observer-masked, Sham-controlled Trial[NCT06088602] | 44 participants (Anticipated) | Interventional | 2023-11-30 | Not yet recruiting | |||
| Evaluation of the Efficacy of Adding Magnesium Sulfate as an Adjuvant to Bupivacaine in Bilateral Ultrasound Guided Paravertebral Block for Laparoscopic Cholecystectomy[NCT05099250] | 50 participants (Actual) | Interventional | 2019-07-15 | Completed | |||
| Analgesic and Hemodynamic Effects of Continuous Epidural Analgesia Compared to Paravertebral Block in Liver Resection Patients[NCT02909322] | Phase 4 | 50 participants (Anticipated) | Interventional | 2016-04-30 | Recruiting | ||
| A Comparison of Ultrasound-assisted Paravertebral Block and General Anesthesia for Outpatient Breast Cancer Surgery, a Prospective Randomized Trial[NCT00645138] | Phase 3 | 40 participants (Anticipated) | Interventional | 2008-04-30 | Completed | ||
| Comparison of the Effects of Perioperative Anesthesia Consumption of Ultrasound Guided Subcostal Transversus Abdominis Plane and Paravertebral Block in Laparoscopic Cholecystectomy[NCT02379780] | 50 participants (Actual) | Interventional | 2014-09-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
This outcome measures the change in the numeric pain scale score from baseline to 2 weeks after treatment. The scale ranges from 0-10. The minimum score is 0 which is defined as no pain and the maximum score is 10, which is defined as the worst pain imaginable. The best possible outcome would be a 0. The worst possible outcome would be a 10. (NCT01670825)
Timeframe: From baseline to 2 weeks after the start of treatment
| Intervention | units on a scale (Mean) |
|---|---|
| Pulsed Radiofrequency + Local Anesthetic Injection | 2.495 |
| Corticosteroid Injection + Sham Pulsed Radiofrequency | 3.694 |
This outcome measures the change in the numeric pain scale score from baseline to 3 months after treatment. The scale ranges from 0-10. The minimum score is 0 which is defined as no pain and the maximum score is 10, which is defined as the worst pain imaginable. The best possible outcome would be a 0. The worst possible outcome would be a 10. (NCT01670825)
Timeframe: From baseline to 3 months after the start of treatment
| Intervention | units on a scale (Mean) |
|---|---|
| Pulsed Radiofrequency + Local Anesthetic Injection | 3.791 |
| Corticosteroid Injection + Sham Pulsed Radiofrequency | 4.441 |
The change in the numeric pain scale score from baseline to 6 months after treatment. The scale ranges from 0-10. The minimum score is 0 which is defined as no pain and the maximum score is 10, which is defined as the worst pain imaginable. The best possible outcome would be a 0. The worst possible outcome would be a 10. (NCT01670825)
Timeframe: From baseline to 6 months after the start of treatment
| Intervention | units on a scale (Mean) |
|---|---|
| Pulsed Radiofrequency + Local Anesthetic Injection | 4.312 |
| Corticosteroid Injection + Sham Pulsed Radiofrequency | 4.765 |
The change in the numeric pain scale score from baseline to 6 weeks after treatment. The scale ranges from 0-10. The minimum score is 0 which is defined as no pain and the maximum score is 10, which is defined as the worst pain imaginable. The best possible outcome would be a 0. The worst possible outcome would be a 10. (NCT01670825)
Timeframe: From baseline to 6 weeks after the start of treatment
| Intervention | units on a scale (Mean) |
|---|---|
| Pulsed Radiofrequency + Local Anesthetic Injection | 3.068 |
| Corticosteroid Injection + Sham Pulsed Radiofrequency | 3.738 |
This outcome measures the change in the numeric pain scale score from baseline to 2 weeks after treatment. The scale ranges from 0-10. The minimum score is 0 which is defined as no pain and the maximum score is 10, which is defined as the worst pain imaginable. The best possible outcome would be a 0. The worst possible outcome would be a 10. (NCT01670825)
Timeframe: From baseline to 2 weeks after the start of treatment
| Intervention | units on a scale (Mean) |
|---|---|
| Pulsed Radiofrequency + Local Anesthetic Injection | 3.392 |
| Corticosteroid Injection + Sham Pulsed Radiofrequency | 4.220 |
This outcome measures the change in the numeric pain scale score from baseline to 3 months after treatment. The scale ranges from 0-10. The minimum score is 0 which is defined as no pain and the maximum score is 10, which is defined as the worst pain imaginable. The best possible outcome would be a 0. The worst possible outcome would be a 10. (NCT01670825)
Timeframe: From baseline to 3 months after the start of treatment
| Intervention | units on a scale (Mean) |
|---|---|
| Pulsed Radiofrequency + Local Anesthetic Injection | 4.000 |
| Corticosteroid Injection + Sham Pulsed Radiofrequency | 4.694 |
This outcome measures the change in the numeric pain scale score from baseline to 6 months after treatment. The scale ranges from 0-10. The minimum score is 0 which is defined as no pain and the maximum score is 10, which is defined as the worst pain imaginable. The best possible outcome would be a 0. The worst possible outcome would be a 10. (NCT01670825)
Timeframe: From baseline to 6 months after the start of treatment
| Intervention | units on a scale (Mean) |
|---|---|
| Pulsed Radiofrequency + Local Anesthetic Injection | 6.761 |
| Corticosteroid Injection + Sham Pulsed Radiofrequency | 7.556 |
This outcome measures the change in the numeric pain scale score from baseline to 6 weeks after treatment. The scale ranges from 0-10. The minimum score is 0 which is defined as no pain and the maximum score is 10, which is defined as the worst pain imaginable. The best possible outcome would be a 0. The worst possible outcome would be a 10. (NCT01670825)
Timeframe: From baseline to 6 weeks after the start of treatment
| Intervention | units on a scale (Mean) |
|---|---|
| Pulsed Radiofrequency + Local Anesthetic Injection | 3.678 |
| Corticosteroid Injection + Sham Pulsed Radiofrequency | 4.410 |
This outcome measures the change in the numeric pain scale score from baseline to 2 weeks after treatment. The scale ranges from 0-10. The minimum score is 0 which is defined as no pain and the maximum score is 10, which is defined as the worst pain imaginable. The best possible outcome would be a 0. The worst possible outcome would be a 10. (NCT01670825)
Timeframe: From baseline to 2 weeks after the start of treatment
| Intervention | units on a scale (Mean) |
|---|---|
| Pulsed Radiofrequency + Local Anesthetic Injection | 5.540 |
| Corticosteroid Injection + Sham Pulsed Radiofrequency | 6.650 |
This outcome measures the change in the numeric pain scale score from baseline to 3 months after treatment. The scale ranges from 0-10. The minimum score is 0 which is defined as no pain and the maximum score is 10, which is defined as the worst pain imaginable. The best possible outcome would be a 0. The worst possible outcome would be a 10. (NCT01670825)
Timeframe: From baseline to 3 months after the start of treatment
| Intervention | units on a scale (Mean) |
|---|---|
| Pulsed Radiofrequency + Local Anesthetic Injection | 6.522 |
| Corticosteroid Injection + Sham Pulsed Radiofrequency | 7.417 |
This outcome measures the change in the numeric pain scale score from baseline to 6 months after treatment. The scale ranges from 0-10. The minimum score is 0 which is defined as no pain and the maximum score is 10, which is defined as the worst pain imaginable. The best possible outcome would be a 0. The worst possible outcome would be a 10. (NCT01670825)
Timeframe: From baseline to 6 months after the start of treatment
| Intervention | units on a scale (Mean) |
|---|---|
| Pulsed Radiofrequency + Local Anesthetic Injection | 6.761 |
| Corticosteroid Injection + Sham Pulsed Radiofrequency | 7.556 |
This outcome measures the change in the numeric pain scale score from baseline to 6 weeks after treatment. The scale ranges from 0-10. The minimum score is 0 which is defined as no pain and the maximum score is 10, which is defined as the worst pain imaginable. The best possible outcome would be a 0. The worst possible outcome would be a 10. (NCT01670825)
Timeframe: From baseline to 6 weeks after the start of treatment
| Intervention | units on a scale (Mean) |
|---|---|
| Pulsed Radiofrequency + Local Anesthetic Injection | 6.583 |
| Corticosteroid Injection + Sham Pulsed Radiofrequency | 6.825 |
This outcome will measure the participant's perceived improvement in sleep using the Athens Insomnia Scale. Scores in this scale can range from 0 to 24. 0 being the best possible outcome and 24 being the worst possible outcome. A score greater than or equal to 6 indicates a presence of insomnia. (NCT01670825)
Timeframe: From baseline to 3 months after the start of treatment
| Intervention | units on a scale (Mean) |
|---|---|
| Pulsed Radiofrequency + Local Anesthetic Injection | 9.539 |
| Corticosteroid Injection + Sham Pulsed Radiofrequency | 9.069 |
This outcome will measure the participant's perceived improvement in sleep using the Athens Insomnia Scale. Scores in this scale can range from 0 to 24. 0 being the best possible outcome and 24 being the worst possible outcome. A score greater than or equal to 6 indicates a presence of insomnia. (NCT01670825)
Timeframe: From baseline to 6 months after the start of treatment
| Intervention | units on a scale (Mean) |
|---|---|
| Pulsed Radiofrequency + Local Anesthetic Injection | 9.256 |
| Corticosteroid Injection + Sham Pulsed Radiofrequency | 9.431 |
This outcome will measure the participant's perceived improvement in sleep using the Athens Insomnia Scale. Scores in this scale can range from 0 to 24. 0 being the best possible outcome and 24 being the worst possible outcome. A score greater than or equal to 6 indicates a presence of insomnia. (NCT01670825)
Timeframe: From baseline to 6 weeks after the start of treatment
| Intervention | units on a scale (Mean) |
|---|---|
| Pulsed Radiofrequency + Local Anesthetic Injection | 10.025 |
| Corticosteroid Injection + Sham Pulsed Radiofrequency | 8.132 |
This outcome will measure the change in severity of depression using the Beck's Depression Inventory. Scores in this inventory can range from 0 to 63. 0 being the best possible outcome and 63 being the worst possible outcome. A score between 14 and 19 indicates mild depression and a score greater than or equal 29 indicates severe depression. (NCT01670825)
Timeframe: From baseline to 3 months after the start of treatment
| Intervention | units on a scale (Mean) |
|---|---|
| Pulsed Radiofrequency + Local Anesthetic Injection | 11.333 |
| Corticosteroid Injection + Sham Pulsed Radiofrequency | 11.972 |
This outcome will measure the change in severity of depression using the Beck's Depression Inventory. Scores in this inventory can range from 0 to 63. 0 being the best possible outcome and 63 being the worst possible outcome. A score between 14 and 19 indicates mild depression and a score greater than or equal 29 indicates severe depression. (NCT01670825)
Timeframe: From baseline to 6 months after the start of treatment
| Intervention | units on a scale (Mean) |
|---|---|
| Pulsed Radiofrequency + Local Anesthetic Injection | 12.590 |
| Corticosteroid Injection + Sham Pulsed Radiofrequency | 12.250 |
This outcome will measure the change in severity of depression using the Beck's Depression Inventory. Scores in this inventory can range from 0 to 63. 0 being the best possible outcome and 63 being the worst possible outcome. A score between 14 and 19 indicates mild depression and a score greater than or equal 29 indicates severe depression. (NCT01670825)
Timeframe: From baseline to 6 weeks after the start of treatment
| Intervention | units on a scale (Mean) |
|---|---|
| Pulsed Radiofrequency + Local Anesthetic Injection | 12.775 |
| Corticosteroid Injection + Sham Pulsed Radiofrequency | 10.842 |
This outcome measures the change in the numeric pain scale score from baseline to 2 weeks after treatment. The scale ranges from 0-10. The minimum score is 0 which is defined as no pain and the maximum score is 10, which is defined as the worst pain imaginable. The best possible outcome would be a 0. The worst possible outcome would be a 10. (NCT01670825)
Timeframe: From baseline to 2 weeks after the start of treatment
| Intervention | units on a scale (Mean) |
|---|---|
| Pulsed Radiofrequency + Local Anesthetic Injection | 4.726 |
| Corticosteroid Injection + Sham Pulsed Radiofrequency | 5.846 |
This outcome measures the change in the numeric pain scale score from baseline to 3 months after treatment. The scale ranges from 0-10. The minimum score is 0 which is defined as no pain and the maximum score is 10, which is defined as the worst pain imaginable. The best possible outcome would be a 0. The worst possible outcome would be a 10. (NCT01670825)
Timeframe: From baseline to 3 months after the start of treatment
| Intervention | units on a scale (Mean) |
|---|---|
| Pulsed Radiofrequency + Local Anesthetic Injection | 5.850 |
| Corticosteroid Injection + Sham Pulsed Radiofrequency | 7.149 |
This outcome measures the change in the numeric pain scale score from baseline to 6 months after treatment. The scale ranges from 0-10. The minimum score is 0 which is defined as no pain and the maximum score is 10, which is defined as the worst pain imaginable. The best possible outcome would be a 0. The worst possible outcome would be a 10. (NCT01670825)
Timeframe: From baseline to 6 months after the start of treatment
| Intervention | units on a scale (Mean) |
|---|---|
| Pulsed Radiofrequency + Local Anesthetic Injection | 6.705 |
| Corticosteroid Injection + Sham Pulsed Radiofrequency | 7.541 |
The change in the numeric pain scale score from baseline to 6 weeks after treatment. The scale ranges from 0-10. The minimum score is 0 which is defined as no pain and the maximum score is 10, which is defined as the worst pain imaginable. The best possible outcome would be a 0. The worst possible outcome would be a 10. (NCT01670825)
Timeframe: From baseline to 6 weeks after the start of treatment
| Intervention | units on a scale (Mean) |
|---|---|
| Pulsed Radiofrequency + Local Anesthetic Injection | 5.354 |
| Corticosteroid Injection + Sham Pulsed Radiofrequency | 6.064 |
This outcome measures what the patient feels they cannot do because headaches. This outcome is measured using the Headache Impact Test. Scores in this test range from range from 36 to 78, with higher scores indicating greater negative impact. A score of less than 50 indicates minimal impact, while a score greater than or equal to 60 indicates headaches are severely impacting one's life. (NCT01670825)
Timeframe: From baseline to 3 months after the start of treatment
| Intervention | units on a scale (Mean) |
|---|---|
| Pulsed Radiofrequency + Local Anesthetic Injection | 59.718 |
| Corticosteroid Injection + Sham Pulsed Radiofrequency | 60.556 |
This outcome measures what the patient feels they cannot do because headaches. This outcome is measured using the Headache Impact Test. Scores in this test range from range from 36 to 78, with higher scores indicating greater negative impact. A score of less than 50 indicates minimal impact, while a score greater than or equal to 60 indicates headaches are severely impacting one's life. (NCT01670825)
Timeframe: From baseline to 6 months after the start of treatment
| Intervention | units on a scale (Mean) |
|---|---|
| Pulsed Radiofrequency + Local Anesthetic Injection | 59.641 |
| Corticosteroid Injection + Sham Pulsed Radiofrequency | 61.389 |
This outcome measures what the patient feels they cannot do because headaches. This outcome is measured using the Headache Impact Test. Scores in this test range from range from 36 to 78, with higher scores indicating greater negative impact. A score of less than 50 indicates minimal impact, while a score greater than or equal to 60 indicates headaches are severely impacting one's life. (NCT01670825)
Timeframe: From baseline to 6 weeks after the start of treatment
| Intervention | units on a scale (Mean) |
|---|---|
| Pulsed Radiofrequency + Local Anesthetic Injection | 60.087 |
| Corticosteroid Injection + Sham Pulsed Radiofrequency | 59.553 |
This outcome will measure the number of days the patient has severe migraine headaches in the week (7 days) prior to the 3 month follow-up visit. A severe headache is defined as a headache with a score greater than or equal to 7 on the numeric pain scale. (NCT01670825)
Timeframe: From baseline to 3 months after the start of treatment
| Intervention | days (Mean) |
|---|---|
| Pulsed Radiofrequency + Local Anesthetic Injection | 2.087 |
| Corticosteroid Injection + Sham Pulsed Radiofrequency | 2.263 |
This outcome will measure the number of days the patient has severe migraine headaches in the week (7 days) prior to the 6 month follow-up visit. A severe headache is defined as a headache with a score greater than or equal to 7 on the numeric pain scale. (NCT01670825)
Timeframe: From baseline to 6 months after the start of treatment
| Intervention | days (Mean) |
|---|---|
| Pulsed Radiofrequency + Local Anesthetic Injection | 2.044 |
| Corticosteroid Injection + Sham Pulsed Radiofrequency | 2.368 |
This outcome will measure the number of days the patient has severe migraine headaches in the week (7 days) prior to the 6 week follow-up visit. A severe headache is defined as a headache with a score greater than or equal to 7 on the numeric pain scale. (NCT01670825)
Timeframe: From baseline to 6 weeks after the start of treatment
| Intervention | days (Mean) |
|---|---|
| Pulsed Radiofrequency + Local Anesthetic Injection | 1.708 |
| Corticosteroid Injection + Sham Pulsed Radiofrequency | 1.810 |
This outcome will measure the number of days the patient has severe occipital neuralgia headaches in the week (7 days) prior to the 6 week follow-up visit. A severe headache is defined as a headache with a score greater than or equal to 7 on the numeric pain scale. (NCT01670825)
Timeframe: 3 months
| Intervention | days (Mean) |
|---|---|
| Pulsed Radiofrequency + Local Anesthetic Injection | 1.846 |
| Corticosteroid Injection + Sham Pulsed Radiofrequency | 1.919 |
This outcome will measure the number of days the patient has severe occipital neuralgia headaches in the week (7 days) prior to the 6 week follow-up visit. A severe headache is defined as a headache with a score greater than or equal to 7 on the numeric pain scale. (NCT01670825)
Timeframe: From baseline to 6 months after the start of treatment
| Intervention | days (Mean) |
|---|---|
| Pulsed Radiofrequency + Local Anesthetic Injection | 2.128 |
| Corticosteroid Injection + Sham Pulsed Radiofrequency | 2.162 |
This outcome will measure the number of days the patient has severe occipital neuralgia headaches in the week (7 days) prior to the 6 week follow-up visit. A severe headache is defined as a headache with a score greater than or equal to 7 on the numeric pain scale. (NCT01670825)
Timeframe: From baseline to 6 weeks after the start of treatment
| Intervention | days (Mean) |
|---|---|
| Pulsed Radiofrequency + Local Anesthetic Injection | 1.436 |
| Corticosteroid Injection + Sham Pulsed Radiofrequency | 1.436 |
7 trials available for bupivacaine and Neuralgia
| Article | Year |
|---|---|
Randomized, double-blind, comparative-effectiveness study comparing pulsed radiofrequency to steroid injections for occipital neuralgia or migraine with occipital nerve tenderness.
Topics: Adult; Anesthetics, Local; Bupivacaine; Delayed-Action Preparations; Double-Blind Method; Drug Thera | 2015 |
Randomized, double-blind, comparative-effectiveness study comparing pulsed radiofrequency to steroid injections for occipital neuralgia or migraine with occipital nerve tenderness.
Topics: Adult; Anesthetics, Local; Bupivacaine; Delayed-Action Preparations; Double-Blind Method; Drug Thera | 2015 |
Randomized, double-blind, comparative-effectiveness study comparing pulsed radiofrequency to steroid injections for occipital neuralgia or migraine with occipital nerve tenderness.
Topics: Adult; Anesthetics, Local; Bupivacaine; Delayed-Action Preparations; Double-Blind Method; Drug Thera | 2015 |
Randomized, double-blind, comparative-effectiveness study comparing pulsed radiofrequency to steroid injections for occipital neuralgia or migraine with occipital nerve tenderness.
Topics: Adult; Anesthetics, Local; Bupivacaine; Delayed-Action Preparations; Double-Blind Method; Drug Thera | 2015 |
Randomized, double-blind, comparative-effectiveness study comparing pulsed radiofrequency to steroid injections for occipital neuralgia or migraine with occipital nerve tenderness.
Topics: Adult; Anesthetics, Local; Bupivacaine; Delayed-Action Preparations; Double-Blind Method; Drug Thera | 2015 |
Randomized, double-blind, comparative-effectiveness study comparing pulsed radiofrequency to steroid injections for occipital neuralgia or migraine with occipital nerve tenderness.
Topics: Adult; Anesthetics, Local; Bupivacaine; Delayed-Action Preparations; Double-Blind Method; Drug Thera | 2015 |
Randomized, double-blind, comparative-effectiveness study comparing pulsed radiofrequency to steroid injections for occipital neuralgia or migraine with occipital nerve tenderness.
Topics: Adult; Anesthetics, Local; Bupivacaine; Delayed-Action Preparations; Double-Blind Method; Drug Thera | 2015 |
Randomized, double-blind, comparative-effectiveness study comparing pulsed radiofrequency to steroid injections for occipital neuralgia or migraine with occipital nerve tenderness.
Topics: Adult; Anesthetics, Local; Bupivacaine; Delayed-Action Preparations; Double-Blind Method; Drug Thera | 2015 |
Randomized, double-blind, comparative-effectiveness study comparing pulsed radiofrequency to steroid injections for occipital neuralgia or migraine with occipital nerve tenderness.
Topics: Adult; Anesthetics, Local; Bupivacaine; Delayed-Action Preparations; Double-Blind Method; Drug Thera | 2015 |
Randomized, double-blind, comparative-effectiveness study comparing pulsed radiofrequency to steroid injections for occipital neuralgia or migraine with occipital nerve tenderness.
Topics: Adult; Anesthetics, Local; Bupivacaine; Delayed-Action Preparations; Double-Blind Method; Drug Thera | 2015 |
Randomized, double-blind, comparative-effectiveness study comparing pulsed radiofrequency to steroid injections for occipital neuralgia or migraine with occipital nerve tenderness.
Topics: Adult; Anesthetics, Local; Bupivacaine; Delayed-Action Preparations; Double-Blind Method; Drug Thera | 2015 |
Randomized, double-blind, comparative-effectiveness study comparing pulsed radiofrequency to steroid injections for occipital neuralgia or migraine with occipital nerve tenderness.
Topics: Adult; Anesthetics, Local; Bupivacaine; Delayed-Action Preparations; Double-Blind Method; Drug Thera | 2015 |
Randomized, double-blind, comparative-effectiveness study comparing pulsed radiofrequency to steroid injections for occipital neuralgia or migraine with occipital nerve tenderness.
Topics: Adult; Anesthetics, Local; Bupivacaine; Delayed-Action Preparations; Double-Blind Method; Drug Thera | 2015 |
Randomized, double-blind, comparative-effectiveness study comparing pulsed radiofrequency to steroid injections for occipital neuralgia or migraine with occipital nerve tenderness.
Topics: Adult; Anesthetics, Local; Bupivacaine; Delayed-Action Preparations; Double-Blind Method; Drug Thera | 2015 |
Randomized, double-blind, comparative-effectiveness study comparing pulsed radiofrequency to steroid injections for occipital neuralgia or migraine with occipital nerve tenderness.
Topics: Adult; Anesthetics, Local; Bupivacaine; Delayed-Action Preparations; Double-Blind Method; Drug Thera | 2015 |
Randomized, double-blind, comparative-effectiveness study comparing pulsed radiofrequency to steroid injections for occipital neuralgia or migraine with occipital nerve tenderness.
Topics: Adult; Anesthetics, Local; Bupivacaine; Delayed-Action Preparations; Double-Blind Method; Drug Thera | 2015 |
Randomized, double-blind, comparative-effectiveness study comparing pulsed radiofrequency to steroid injections for occipital neuralgia or migraine with occipital nerve tenderness.
Topics: Adult; Anesthetics, Local; Bupivacaine; Delayed-Action Preparations; Double-Blind Method; Drug Thera | 2015 |
Randomized, double-blind, comparative-effectiveness study comparing pulsed radiofrequency to steroid injections for occipital neuralgia or migraine with occipital nerve tenderness.
Topics: Adult; Anesthetics, Local; Bupivacaine; Delayed-Action Preparations; Double-Blind Method; Drug Thera | 2015 |
Randomized, double-blind, comparative-effectiveness study comparing pulsed radiofrequency to steroid injections for occipital neuralgia or migraine with occipital nerve tenderness.
Topics: Adult; Anesthetics, Local; Bupivacaine; Delayed-Action Preparations; Double-Blind Method; Drug Thera | 2015 |
Randomized, double-blind, comparative-effectiveness study comparing pulsed radiofrequency to steroid injections for occipital neuralgia or migraine with occipital nerve tenderness.
Topics: Adult; Anesthetics, Local; Bupivacaine; Delayed-Action Preparations; Double-Blind Method; Drug Thera | 2015 |
Randomized, double-blind, comparative-effectiveness study comparing pulsed radiofrequency to steroid injections for occipital neuralgia or migraine with occipital nerve tenderness.
Topics: Adult; Anesthetics, Local; Bupivacaine; Delayed-Action Preparations; Double-Blind Method; Drug Thera | 2015 |
Randomized, double-blind, comparative-effectiveness study comparing pulsed radiofrequency to steroid injections for occipital neuralgia or migraine with occipital nerve tenderness.
Topics: Adult; Anesthetics, Local; Bupivacaine; Delayed-Action Preparations; Double-Blind Method; Drug Thera | 2015 |
Randomized, double-blind, comparative-effectiveness study comparing pulsed radiofrequency to steroid injections for occipital neuralgia or migraine with occipital nerve tenderness.
Topics: Adult; Anesthetics, Local; Bupivacaine; Delayed-Action Preparations; Double-Blind Method; Drug Thera | 2015 |
Randomized, double-blind, comparative-effectiveness study comparing pulsed radiofrequency to steroid injections for occipital neuralgia or migraine with occipital nerve tenderness.
Topics: Adult; Anesthetics, Local; Bupivacaine; Delayed-Action Preparations; Double-Blind Method; Drug Thera | 2015 |
Randomized, double-blind, comparative-effectiveness study comparing pulsed radiofrequency to steroid injections for occipital neuralgia or migraine with occipital nerve tenderness.
Topics: Adult; Anesthetics, Local; Bupivacaine; Delayed-Action Preparations; Double-Blind Method; Drug Thera | 2015 |
Study protocol for a pilot, randomised, double-blinded, placebo controlled trial of perineural local anaesthetics and steroids for chronic post-traumatic neuropathic pain in the ankle and foot: the PREPLANS study.
Topics: Anesthetics, Local; Ankle; Ankle Injuries; Bupivacaine; Chronic Pain; Double-Blind Method; Feasibili | 2016 |
Treatment of ilioinguinal nerve entrapment - a randomized controlled trial.
Topics: Adult; Anesthetics, Local; Bupivacaine; Cross-Over Studies; Female; Humans; Middle Aged; Nerve Compr | 2011 |
Effect of the addition of clonidine to locally administered bupivacaine on acute and chronic postmastectomy pain.
Topics: Acute Pain; Administration, Topical; Adult; Analgesics; Anesthetics, Local; Breast Neoplasms; Bupiva | 2013 |
Comparison of epidural analgesia and intercostal nerve cryoanalgesia for post-thoracotomy pain control.
Topics: Aged; Analgesia; Analgesia, Epidural; Analgesics; Bupivacaine; Chronic Disease; Cryotherapy; Female; | 2008 |
Comparison of epidural analgesia and intercostal nerve cryoanalgesia for post-thoracotomy pain control.
Topics: Aged; Analgesia; Analgesia, Epidural; Analgesics; Bupivacaine; Chronic Disease; Cryotherapy; Female; | 2008 |
Comparison of epidural analgesia and intercostal nerve cryoanalgesia for post-thoracotomy pain control.
Topics: Aged; Analgesia; Analgesia, Epidural; Analgesics; Bupivacaine; Chronic Disease; Cryotherapy; Female; | 2008 |
Comparison of epidural analgesia and intercostal nerve cryoanalgesia for post-thoracotomy pain control.
Topics: Aged; Analgesia; Analgesia, Epidural; Analgesics; Bupivacaine; Chronic Disease; Cryotherapy; Female; | 2008 |
Comparison of epidural analgesia and intercostal nerve cryoanalgesia for post-thoracotomy pain control.
Topics: Aged; Analgesia; Analgesia, Epidural; Analgesics; Bupivacaine; Chronic Disease; Cryotherapy; Female; | 2008 |
Comparison of epidural analgesia and intercostal nerve cryoanalgesia for post-thoracotomy pain control.
Topics: Aged; Analgesia; Analgesia, Epidural; Analgesics; Bupivacaine; Chronic Disease; Cryotherapy; Female; | 2008 |
Comparison of epidural analgesia and intercostal nerve cryoanalgesia for post-thoracotomy pain control.
Topics: Aged; Analgesia; Analgesia, Epidural; Analgesics; Bupivacaine; Chronic Disease; Cryotherapy; Female; | 2008 |
Comparison of epidural analgesia and intercostal nerve cryoanalgesia for post-thoracotomy pain control.
Topics: Aged; Analgesia; Analgesia, Epidural; Analgesics; Bupivacaine; Chronic Disease; Cryotherapy; Female; | 2008 |
Comparison of epidural analgesia and intercostal nerve cryoanalgesia for post-thoracotomy pain control.
Topics: Aged; Analgesia; Analgesia, Epidural; Analgesics; Bupivacaine; Chronic Disease; Cryotherapy; Female; | 2008 |
The effects of epidural blockade on the acute pain in herpes zoster.
Topics: Acute Disease; Acyclovir; Adult; Aged; Aged, 80 and over; Analgesia, Epidural; Analysis of Variance; | 1999 |
Cerebrospinal norepinephrine concentrations and the duration of epidural analgesia.
Topics: Analgesia, Epidural; Analysis of Variance; Anesthesia, Epidural; Bupivacaine; Female; Herniorrhaphy; | 1990 |
58 other studies available for bupivacaine and Neuralgia
| Article | Year |
|---|---|
Preventive Intrathecal Injection of Bupivacaine Alleviated Microglia Activation and Neuropathic Pain in a Rat Model of Chronic Constriction Injury.
Topics: Animals; Bupivacaine; Constriction; Crush Injuries; Cytokines; HMGB1 Protein; Hyperalgesia; Injectio | 2022 |
Treatment of Ocular Neuralgia After Refractive Surgery With Bilateral Orbital Steroid and Anesthetic Injections.
Topics: Anesthetics, Local; Bupivacaine; Eye Pain; Glucocorticoids; Humans; Injections, Intraocular; Male; N | 2019 |
Management of neuropathic pain following traumatic brachial plexus injury with neurolysis and oral gabapentin: A case report.
Topics: Adult; Aged; Analgesics; Brachial Plexus; Brachial Plexus Neuropathies; Bupivacaine; Gabapentin; Hum | 2019 |
Case Report: Treatment of Refractory Post-Surgical Neuralgia With Erector Spinae Plane Block.
Topics: Aged; Anesthetics, Local; Anti-Inflammatory Agents; Bupivacaine; Chronic Pain; Dexamethasone; Humans | 2020 |
Ultrasound guided low thoracic erector spinae plane block for management of acute herpes zoster.
Topics: Aged; Anesthetics, Local; Bupivacaine; Herpes Zoster; Humans; Male; Nerve Block; Neuralgia; Pain Man | 2018 |
Palliative care with cervical intrathecal infusion and external pump for a late-stage cancer patient with refractory pain: A case report.
Topics: Aged; Analgesia, Patient-Controlled; Analgesics, Opioid; Anesthetics, Local; Bupivacaine; Carcinoma, | 2018 |
Atypical distribution of local anesthetic solution in a patient with distal adductor canal catheter.
Topics: Aged, 80 and over; Analgesia; Anesthesia, Local; Anesthetics, Local; Bupivacaine; Catheters; Foot; H | 2018 |
Pain in the hand caused by a previously undescribed mechanism with possible relevance for understanding regional pain.
Topics: Acupuncture Points; Adult; Anesthetics, Local; Bupivacaine; Female; Hand; Humans; Injections, Intrav | 2018 |
A new lacrimal neuralgia, a new nerve blockade procedure.
Topics: Anesthetics, Local; Bupivacaine; Female; Humans; Lacrimal Apparatus Diseases; Middle Aged; Nerve Blo | 2014 |
Effects of various antiepileptics used to alleviate neuropathic pain on compound action potential in frog sciatic nerves: comparison with those of local anesthetics.
Topics: Action Potentials; Anesthetics, Local; Animals; Anticonvulsants; Bupivacaine; Carbamazepine; Humans; | 2014 |
Nummular headache in a patient with ipsilateral occipital neuralgia--a case report.
Topics: Amines; Analgesics; Anesthetics, Local; Bupivacaine; Comorbidity; Cyclohexanecarboxylic Acids; Femal | 2014 |
Infratrochlear nerve block for a new infratrochlear neuralgia.
Topics: Anesthetics, Local; Bupivacaine; Female; Humans; Middle Aged; Nerve Block; Neuralgia; Trochlear Nerv | 2016 |
External Nasal Neuralgia: A Neuropathic Pain Within the Territory of the External Nasal Nerve.
Topics: Aged; Anesthetics, Local; Bupivacaine; Female; Humans; Nerve Block; Neuralgia; Nose | 2015 |
Conditioned place preference and spontaneous dorsal horn neuron activity in chronic constriction injury model in rats.
Topics: Anesthetics, Local; Animals; Behavior, Animal; Bupivacaine; Conditioning, Psychological; Disease Mod | 2015 |
Successful Management of Corneal Neuropathic Pain with Intrathecal Targeted Drug Delivery.
Topics: Adult; Analgesics; Bupivacaine; Cervical Vertebrae; Cornea; Female; Fentanyl; Humans; Infusion Pumps | 2016 |
Ultrasound Guided Intercostobrachial Nerve Blockade in Patients with Persistent Pain after Breast Cancer Surgery: A Pilot Study.
Topics: Adult; Aged; Anesthetics, Local; Breast Neoplasms; Bupivacaine; Denmark; Double-Blind Method; Female | 2016 |
Lacrimal Nerve Blocks for Three New Cases of Lacrimal Neuralgia.
Topics: Adult; Anesthetics, Local; Bupivacaine; Female; Humans; Lacrimal Apparatus; Middle Aged; Nerve Block | 2017 |
Early blockade of injured primary sensory afferents reduces glial cell activation in two rat neuropathic pain models.
Topics: Animals; Biomarkers; Bupivacaine; CD11b Antigen; Disease Models, Animal; Ganglia, Spinal; Glial Fibr | 2009 |
Comparison of actions of systemically and locally administrated local anaesthetics in diabetic rats with painful neuropathy.
Topics: Anesthetics, Local; Animals; Bupivacaine; Diabetes Mellitus, Experimental; Disease Models, Animal; F | 2013 |
Ultrasound-guided transversus abdominis plane catheter for chronic abdominal pain.
Topics: Abdominal Muscles; Abdominal Pain; Abdominal Wall; Adolescent; Anesthetics, Local; Bupivacaine; Cath | 2013 |
Radicular pain in post lumbar surgery syndrome: the significance of transforaminal injection of steroids.
Topics: Adolescent; Adult; Aged; Anesthetics, Local; Anti-Inflammatory Agents; Bupivacaine; Drug Therapy, Co | 2013 |
Chronic perineal pain caused by pudendal nerve entrapment: anatomy and CT-guided perineural injection technique.
Topics: Adult; Aged; Anesthetics, Local; Bupivacaine; Chronic Disease; Glucocorticoids; Humans; Injections; | 2003 |
Why CT-guided?
Topics: Anesthetics, Local; Bupivacaine; Chronic Disease; Glucocorticoids; Humans; Injections; Methylprednis | 2004 |
Severe ocular pain secondary to occipital neuralgia following vitrectomy surgery.
Topics: Aged; Anesthetics, Local; Anti-Inflammatory Agents; Bupivacaine; Cranial Nerves; Female; Humans; Mal | 2004 |
Sacral postherpetic neuralgia and successful treatment using a paramedial approach to the ganglion impar.
Topics: Aged; Anesthetics, Local; Bupivacaine; Female; Ganglia, Sympathetic; Ganglionic Blockers; Herpes Zos | 2004 |
Relief of pain in acute herpes zoster by nerve blocks and possible prevention of post-herpetic neuralgia.
Topics: Aged; Anesthetics, Local; Anti-Inflammatory Agents; Bupivacaine; Epinephrine; Female; Herpes Zoster; | 2005 |
Cervicogenic headache in patients with presumed migraine: missed diagnosis or misdiagnosis?
Topics: Adult; Aged; Anesthetics, Local; Bupivacaine; Cervical Plexus; Cervical Vertebrae; Chronic Disease; | 2005 |
Nerve-stimulator-guided repeated pudendal nerve block for treatment of pudendal neuralgia.
Topics: Analgesics; Analgesics, Opioid; Anesthetics, Local; Bupivacaine; Clonidine; Electric Stimulation; Ep | 2006 |
Nerve conduction blockade in the sciatic nerve prevents but does not reverse the activation of p38 mitogen-activated protein kinase in spinal microglia in the rat spared nerve injury model.
Topics: Anesthetics, Local; Animals; Behavior, Animal; Blotting, Western; Bupivacaine; Disease Models, Anima | 2007 |
Re: characteristics and treatment of headache after traumatic brain injury.
Topics: Adrenal Cortex Hormones; Analgesics; Anesthetics, Local; Brain Injuries; Bupivacaine; Humans; Neural | 2007 |
The effect of intra-neural local anaesthetic infusion on pain following major lower limb amputation.
Topics: Aged; Amputation, Surgical; Anesthesia, Local; Anesthetics, Local; Bupivacaine; Cohort Studies; Fema | 2008 |
Intercostal nerve block.
Topics: Anesthesia, Local; Anesthetics; Bupivacaine; Humans; Intercostal Nerves; Nerve Block; Neuralgia; Pal | 1984 |
Pain relief in herpes zoster.
Topics: Adolescent; Adult; Aged; Analgesics; Bupivacaine; Drug Combinations; Female; Herpes Zoster; Humans; | 1983 |
Facial causalgia: report of case.
Topics: Bupivacaine; Causalgia; Facial Nerve; Ganglia, Sympathetic; Humans; Male; Middle Aged; Nerve Block; | 1980 |
Occipital neuralgia in a football player: a case report.
Topics: Adult; Anesthetics, Local; Bupivacaine; Cervical Plexus; Diagnosis, Differential; Football; Headache | 1995 |
A thermographic study of paravertebral analgesia.
Topics: Adult; Aged; Autonomic Nerve Block; Blood Pressure; Body Temperature; Bupivacaine; Chronic Disease; | 1995 |
A thermographic study of paravertebral analgesia.
Topics: Adult; Aged; Autonomic Nerve Block; Blood Pressure; Body Temperature; Bupivacaine; Chronic Disease; | 1995 |
A thermographic study of paravertebral analgesia.
Topics: Adult; Aged; Autonomic Nerve Block; Blood Pressure; Body Temperature; Bupivacaine; Chronic Disease; | 1995 |
A thermographic study of paravertebral analgesia.
Topics: Adult; Aged; Autonomic Nerve Block; Blood Pressure; Body Temperature; Bupivacaine; Chronic Disease; | 1995 |
A thermographic study of paravertebral analgesia.
Topics: Adult; Aged; Autonomic Nerve Block; Blood Pressure; Body Temperature; Bupivacaine; Chronic Disease; | 1995 |
A thermographic study of paravertebral analgesia.
Topics: Adult; Aged; Autonomic Nerve Block; Blood Pressure; Body Temperature; Bupivacaine; Chronic Disease; | 1995 |
A thermographic study of paravertebral analgesia.
Topics: Adult; Aged; Autonomic Nerve Block; Blood Pressure; Body Temperature; Bupivacaine; Chronic Disease; | 1995 |
A thermographic study of paravertebral analgesia.
Topics: Adult; Aged; Autonomic Nerve Block; Blood Pressure; Body Temperature; Bupivacaine; Chronic Disease; | 1995 |
A thermographic study of paravertebral analgesia.
Topics: Adult; Aged; Autonomic Nerve Block; Blood Pressure; Body Temperature; Bupivacaine; Chronic Disease; | 1995 |
A thermographic study of paravertebral analgesia.
Topics: Adult; Aged; Autonomic Nerve Block; Blood Pressure; Body Temperature; Bupivacaine; Chronic Disease; | 1995 |
A thermographic study of paravertebral analgesia.
Topics: Adult; Aged; Autonomic Nerve Block; Blood Pressure; Body Temperature; Bupivacaine; Chronic Disease; | 1995 |
A thermographic study of paravertebral analgesia.
Topics: Adult; Aged; Autonomic Nerve Block; Blood Pressure; Body Temperature; Bupivacaine; Chronic Disease; | 1995 |
A thermographic study of paravertebral analgesia.
Topics: Adult; Aged; Autonomic Nerve Block; Blood Pressure; Body Temperature; Bupivacaine; Chronic Disease; | 1995 |
A thermographic study of paravertebral analgesia.
Topics: Adult; Aged; Autonomic Nerve Block; Blood Pressure; Body Temperature; Bupivacaine; Chronic Disease; | 1995 |
A thermographic study of paravertebral analgesia.
Topics: Adult; Aged; Autonomic Nerve Block; Blood Pressure; Body Temperature; Bupivacaine; Chronic Disease; | 1995 |
A thermographic study of paravertebral analgesia.
Topics: Adult; Aged; Autonomic Nerve Block; Blood Pressure; Body Temperature; Bupivacaine; Chronic Disease; | 1995 |
Long-term epidural analgesia for pregnancy-induced intercostal neuralgia.
Topics: Adult; Analgesia, Epidural; Bupivacaine; Female; Gestational Age; Humans; Intercostal Nerves; Neural | 1995 |
[Epidural anesthesia in the treatment of painful diabetic neuropathy].
Topics: Aged; Anesthesia, Epidural; Bupivacaine; Diabetic Neuropathies; Female; Humans; Leg; Neuralgia | 1995 |
Epidural coadministration of ketamine, morphine and bupivacaine attenuates post-herpetic neuralgia--a case report.
Topics: Adult; Analgesia, Epidural; Bupivacaine; Drug Therapy, Combination; Herpes Zoster; Humans; Ketamine; | 1996 |
Long-term epidural ketamine, morphine and bupivacaine attenuate reflex sympathetic dystrophy neuralgia.
Topics: Adult; Analgesia, Epidural; Analgesics, Opioid; Anesthetics, Local; Bupivacaine; Excitatory Amino Ac | 1998 |
Another cause for transient radicular pain.
Topics: Anesthetics, Local; Back Pain; Bupivacaine; Exanthema; Female; Herpes Genitalis; Humans; Nerve Block | 1999 |
Urgent local anaesthetic drug alarm.
Topics: Adolescent; Adult; Anesthetics, Local; Bupivacaine; Fat Necrosis; Female; Humans; Male; Mydriasis; N | 1999 |
Transient neurologic symptoms after epidural analgesia in a five-year-old child.
Topics: Acetaminophen; Analgesia, Epidural; Analgesics, Non-Narcotic; Analgesics, Opioid; Anesthesia, Epidur | 2000 |
The effects of famciclovir and epidural block in the treatment of herpes zoster.
Topics: 2-Aminopurine; Acyclovir; Adult; Analgesia, Epidural; Analysis of Variance; Anesthetics, Local; Anti | 2001 |
Drug-induced liver disease during continuous epidural block with bupivacaine.
Topics: Aged; Aged, 80 and over; Analgesia, Epidural; Anesthetics, Local; Bupivacaine; Chemical and Drug Ind | 2001 |
[Usefulness of epidural administration of ketamine for relief of postherpetic neuralgia].
Topics: Aged; Analgesia, Epidural; Bupivacaine; Drug Therapy, Combination; Female; Herpes Zoster; Humans; In | 2001 |
Inefficacy of high-dose transdermal fentanyl in a patient with neuropathic pain, a case report.
Topics: Administration, Cutaneous; Analgesia, Epidural; Analgesics, Opioid; Anesthetics, Local; Breast Neopl | 2001 |
Epidural injection of local anesthetic and steroids for relief of pain secondary to herpes zoster.
Topics: Adult; Aged; Anesthesia, Epidural; Bupivacaine; Drug Therapy, Combination; Herpes Zoster; Humans; In | 1978 |
Chronic headache resulting from postoperative supraorbital neuralgia.
Topics: Bupivacaine; Chronic Disease; Headache; Humans; Nerve Block; Neuralgia; Orbit; Postoperative Complic | 1992 |
Treatment for herpes zoster ophthalmicus: stellate ganglion block as a treatment for acute pain and prevention of postherpetic neuralgia.
Topics: Acute Disease; Aged; Aged, 80 and over; Autonomic Nerve Block; Bupivacaine; Female; Herpes Zoster Op | 1991 |
Chronic headache resulting from postoperative supraorbital neuralgia.
Topics: Bupivacaine; Chronic Disease; Clonazepam; Female; Headache; Humans; Middle Aged; Nerve Block; Neural | 1991 |
Local anaesthetic block therapy of posttraumatic neuralgia of the infraorbital nerve.
Topics: Adult; Antidepressive Agents, Tricyclic; Bupivacaine; Cranial Nerve Diseases; Female; Humans; Male; | 1990 |
Poststernotomy neuralgia: a new pain syndrome.
Topics: Adult; Aged; Bupivacaine; Cicatrix; Ethanol; Humans; Intercostal Nerves; Male; Middle Aged; Nerve Bl | 1989 |
Horner's syndrome after intrapleural anesthesia with bupivacaine for post-herpetic neuralgia.
Topics: Aged; Bupivacaine; Female; Herpes Zoster; Horner Syndrome; Humans; Injections; Neuralgia; Pleura | 1988 |
Nerve blocks utilizing 0.5% bupivacaine in the treatment of post-herpetic neuralgia.
Topics: Adult; Aged; Bupivacaine; Female; Herpes Zoster; Humans; Male; Middle Aged; Nerve Block; Neuralgia | 1987 |
[Perivasal anesthetic infiltration as a simple method for peripheral sympathetic blockade in pain states of the extremities (sympathalgias)].
Topics: Afferent Pathways; Arm; Autonomic Nerve Block; Bupivacaine; Dose-Response Relationship, Drug; Humans | 1985 |
Treatment of intractable pain by bupivacaine nerve-block.
Topics: Aged; Analgesia; Anesthesia, Conduction; Anesthetics, Local; Bupivacaine; Female; Humans; Male; Midd | 1971 |
Relieving pain in the terminally ill.
Topics: Administration, Oral; Alcohols; Anesthesia, Spinal; Antidepressive Agents; Autonomic Nerve Block; Bu | 1973 |